Roger Cauich-Kumul

Roger Cauich-Kumul

Auto-generated profile, based on publicly available information

Roger Cauich-Kumul

Departamento de Ciencias Farmacéuticas, División de Ciencias de la Salud, Universidad Autónoma del Estado de Quintana Roo, Chetumal, México

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2022 in Journal of Molecular Structure
Verified
Journal Article
Closed access
DCDavid Cáceres-Castillo
David Cáceres-Castillo
GMGumersindo Mirón-López
Gumersindo Mirón-López
MGMaría C. García-López
María C. García-López
RCRodrigo Chan-Navarro
Rodrigo Chan-Navarro
RQRamiro Quijano
Ramiro Quijano
AHAngel D. Herrera-España
Angel D. Herrera-España

1 June 2022 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Wendy Herrera-MoralesWendy Herrera-Morales
Wendy Herrera-Morales
LRLeticia Ramírez-Lugo
Leticia Ramírez-Lugo
RCRoger Cauich-Kumul
Roger Cauich-Kumul
EMEric Murillo-Rodríguez
Eric Murillo-Rodríguez
Luis Núñez-JaramilloLuis Núñez-Jaramillo
Luis Núñez-Jaramillo
Attention-deficit hyperactivity disorder is a neurodevelopmental disorder diagnosed primarily in children, although it is also present in adults. Patients present inattention, impulsivity, and hyperactivity symptoms that create difficulties in their daily lives. Pharmacological treatment with stimulants or non-stimulants is used most commonly to reduce ADHD symptoms. Although generally effective and safe, pharmacological treatments have different effects among patients, including lack of response and adverse reactions. The reasons for these differences are not fully understood, but they may derive from the highly diverse etiology of ADHD. Strategies to guide optimal pharmacological treatment selection on the basis of individual patients’ physiological markers are being developed. In this review, we describe the main pharmacological ADHD treatments used and their main drawbacks. We present alternatives under study that would allow the customization of pharmacological treatments to overcome these drawbacks and achieve more reliable improvement of ADHD symptoms.